Hypoglycaemia unawareness: A reversible problem?

Diabetic Medicine

Volumn 18, Issue SUPPL. 1, 2001, Pages 11-14

  Amiel, S A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; CASE REPORT; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; METHODOLOGY; PRIMARY PREVENTION; PROGNOSIS; RECURRENT DISEASE; RISK ASSESSMENT;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; INCIDENCE; INSULIN; PRIMARY PREVENTION; PROGNOSIS; RECURRENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 0035221799     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2001.00456-6.x     Document Type: Article

References (26)

1. Bolli G, de Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P et al. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 1983; 32: 134-141.
2. Landstedt-Hallin L, Adamson U, Lins PE. Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes. J Clin Endocrinol Metab 1999; 84: 3140-3145.
3. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994; 17: 697-703.
4. Fanelli C, Pampanelli S, Lalli C, Del Sindaco P, Ciofetta M, Lepore M et al. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes 1997; 46: 1172-1181.
5. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988; 37: 901-907.
6. Fanelli CG, Paramore DS, Hershey T, Terkamp C, Ovalle F, Craft S et al. Impact of nocturnal hypoglycemia on hypoglycemic dysfunction in type 1 diabetes. Diabetes 1998; 47: 1920-1927.
7. Maran A, Lomas J, Macdonald IA, Amiel SA. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM. Diabetologia 1995; 38: 1412-1418.
8. Evans ML, Pernet A, Lomas J, Jones J, Amiel SA. Delay in onset of awareness of acute hypoglycemia and of restoration of cognitive performance during recovery. Diabetes Care 2000; 23: 893-897.
9. Cox DJ, Gonder-Frederick LA, Kovatchev BP, Julian DM, Clarke WL. Progressive hypoglycemia's impact on driving simulation performance. Occurrence, awareness and correction. Diabetes Care 2000; 23: 163-170.
10. Levin BE, Dunn-Meynell AA, Routh VH. Brain glucose sensing and body energy homeostasis: role in obesity and diabetes. Am J Physiol 1999; 276 (5, Part 2): R1223-1231.
11. Jones TW, Porter P, Sherwin RS, Davis EA, O'Leary P, Frazer F et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998; 338: 1657-1662.
12. George E, Bedford C, Peacey SR, Hardisty CA, Heller SR. Further evidence for a high incidence of nocturnal hypoglycaemia in IDDM: no effect of dose for dose transfer between human and porcine insulins Diabet Med 1997; 14: 442-448.
13. Matyka KA, Wigg L, Pramming S, Stores G, Dunger DB. Cognitive function and mood after profound nocturnal hypoglycaemia in prepubertal children with conventional insulin treatment for diabetes. Arch Dis Child 1999; 81: 138-142.
14. The Diabetes Control and Complications Trial. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 1996; 124: 379-388.
15. Austin EJ, Deary IJ. Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. Diabetes Care 1999; 22: 1273-1277.
16. Rovet J, Alvarez M. Attentional functioning in children and adolescents with IDDM. Diabetes Care 1997; 20: 803-810.
17. Price TB, Rothman DL, Shulman RG. NMR of glycogen in exercise. Proc Nutr Soc 1999; 58: 851-859.
18. Siler SQ, Neese RA, Christiansen MP, Hellerstein MK. The inhibition of gluconeogenesis following alcohol in humans. Am J Physiol 1998; 275 (5, part 1): E897-907.
19. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994; 344: 283-287.
20. Morris AD, Boyle DI, McMahon AD, Pearce H, Evans JM, Newton RW et al. ACE inhibitor use is associated with hospitalization for hypoglycemia in patients with diabetes. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside, Scotland. Medicines Monitoring Unit ACE. Diabetes Care 1997; 20: 1363-1367.
21. Airey CM, Williams DR, Martin PG, Bennett CM, Spoor PA. Hypoglycaemia induced by exogenous insulin - 'human' and animal insulin compared. Diabet Med 2000; 17: 416-432.
22. Heller SR, Amiel SA, Mansell P. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. UK Lispro Study Group. Diabetes Care 1999; 22: 1607-1611.
23. Pieber TR, Eugene-Jolchine I, Derobert E. Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type diabetes. Diabetes Care 2000; 23: 157-162.
24. Kanc K, Janssen MM, Keulen ET, Jacobs MA, Popp-Snijders C, Snoek FJ et al. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and symptoms of hypoglycaemia in IDDM. Diabetologia 1998; 41: 322-329.
25. Orre-Pettersson AC, Lindstrom T, Bergmark V, Arnqvist HJ. The snack is critical for the blood glucose profile during treatment with regular insulin preprandially. J Intern Med 1999; 245: 41-45.
26. Ronnemaa T, Viikari J Reducing snacks when switching from conventional soluble to lispro insulin treatment: effects on glycaemic control and hypoglycaemia Diabet Med 1998; 15: 601-607.